Related Experiment Video
Updated: Aug 5, 2026

Identification of Footprints of RNA:Protein Complexes via RNA Immunoprecipitation in Tandem Followed by Sequencing (RIPiT-Seq)
Published on: July 10, 2019
Possible Mechanisms of mRNA-LNP Degradation: A Comprehensive Review
M D Faizul Hussain Khan1, Tahsina Islam2, Abhishek Mishra1
1Viral Vectors and Vaccines Bioprocessing Group, Department of Bioengineering, McGill University, Montreal, QC H3A 0G4, Canada.
Messenger RNA-lipid nanoparticle (mRNA-LNP) drug products face stability challenges due to physicochemical factors, impacting storage and efficacy. This review details instability factors, degradation mechanisms, and stabilization strategies for mRNA-LNP formulations.
Area of Science:
- Biotechnology
- Pharmaceutical Sciences
- Drug Delivery
Background:
- Messenger RNA-lipid nanoparticle (mRNA-LNP) formulations are a significant advancement in prophylactic and therapeutic applications.
- The inherent instability of mRNA-LNP products necessitates stringent ultra-cold chain storage, limiting global distribution.
Purpose of the Study:
- To comprehensively review the physicochemical factors contributing to mRNA-LNP instability.
- To elucidate the molecular degradation mechanisms affecting mRNA and lipid nanoparticle components.
- To summarize current stabilization strategies and analytical detection methods for mRNA-LNP products.
Main Methods:
- Literature review focusing on physicochemical instability factors (temperature, pH, light, oxidation, aggregation, shear stress, humidity).
- Analysis of molecular degradation pathways impacting mRNA and LNP integrity.
- Compilation of reported stabilization techniques and analytical quantification methods.
Main Results:
- Identified key physicochemical factors that compromise mRNA-LNP integrity.
- Detailed the molecular mechanisms leading to structural and functional deterioration.
- Summarized diverse strategies for enhancing mRNA-LNP stability and methods for degradation assessment.
Conclusions:
- Understanding mRNA-LNP instability drivers is critical for maintaining product efficacy and safety.
- Effective stabilization strategies and analytical tools are essential for advancing nucleic acid-based therapeutics.
- Overcoming stability challenges will facilitate broader application and distribution of mRNA-LNP drug products.
More Related Videos
Related Concept Videos
Nuclear Export of mRNA
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
RNA Stability

